IP Verse

Competitive analysis in Organic Medicines industry

Latest patents granted in the Organic Medicines industry

Patent:
EP2571517
Grant Date:
Oct 16, 2024
Title:
Long - Acting Formulations Of Insulins
Applicant:
SANOFI
Patent:
EP3045466
Grant Date:
Oct 16, 2024
Title:
(2S,3R,4S,5S,6R)-2-[4-Chloro-3-(4-Ethoxy-Benzyl)-Phenyl]-6-Hydroxymethyl-2-Methoxy-Tetrahydro-Pyran-3,4,5-Triol Propylene Glycol Solvate As Sgt2 Inhibitor For The Treatment Of Diabetes
Applicant:
ASTRAZENECA AB
Patent:
EP2819699
Grant Date:
Oct 16, 2024
Title:
Controlled Release Compositions And Their Methods Of Use
Applicant:
BAYER NEW ZEALAND LIMITED
Patent:
EP2736487
Grant Date:
Aug 28, 2024
Title:
New (Trimethoxyphenylamino)Pyrimidinyl Formulations
Applicant:
RIGEL PHARMACEUTICALS, INC.
Patent:
EP2608789
Grant Date:
Aug 21, 2024
Title:
Therapeutic Uses Of 1-[2-(2,4-Dimethyl-Phenylsulfanyl)Phenyl]Piperazine
Applicant:
H. LUNDBECK A/S
Patent:
EP3076983
Grant Date:
Aug 14, 2024
Title:
Ionic Aqueous Compositions
Applicant:
GEROLYMATOS INTERNATIONAL S.A.
Patent:
EP2694072
Grant Date:
Aug 7, 2024
Title:
Combinations Of Akt Inhibitor Compounds And Abiraterone, And Methods Of Use
Applicant:
GENENTECH, INC.
Patent:
EP2687103
Grant Date:
Jul 24, 2024
Title:
Aqueous Transparent Oil-In-Water Emulsion Comprising An Emulsified Carotenoid
Applicant:
BASF SE
Patent:
EP3206987
Grant Date:
Jul 24, 2024
Title:
Nanoparticles For Photodynamic Therapy, X-Ray Induced Photodynamic Therapy, Radiotherapy, Chemotherapy, Immunotherapy, And Any Combination Thereof
Applicant:
THE UNIVERSITY OF CHICAGO
Patent:
EP3102208
Grant Date:
Jul 17, 2024
Title:
Crystalline Polymorphs Of The Free Base Of 2-Hydroxy-6-((2-(1-Isopropyl-1H-Pyrazol-5-Yl)Pyridin-3-Yl)Methoxy)Benzaldehyde
Applicant:
GLOBAL BLOOD THERAPEUTICS, INC.

Top patents facing oppositions in Organic Medicines industry

Patent:
EP2269603
Grant Date:
May 20, 2015
Title:
Treatment Of Solid Tumours With Rapamycin Derivatives
Applicant:
NOVARTIS PHARMA GMBH
Oppositions:
144
Patent:
EP2425821
Grant Date:
May 10, 2017
Title:
Pharmaceutical Preparation Containing Oxycodone And Naloxone
Applicant:
MUNDIPHARMA MEDICAL CEE GMBH
Oppositions:
143
Patent:
EP2425824
Grant Date:
May 10, 2017
Title:
Pharmaceutical Preparation Containing Oxycodone And Naloxone
Applicant:
MUNDIPHARMA PHARMACEUTICALS S.L.
Oppositions:
143
Patent:
EP3626270
Grant Date:
Oct 11, 2023
Title:
New Use
Applicant:
NOVARTIS AG
Oppositions:
112
Patent:
EP2099453
Grant Date:
Sep 6, 2017
Title:
Combination Therapy Of Substituted Oxazolidinones
Applicant:
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Oppositions:
108
Patent:
EP2371361
Grant Date:
Aug 7, 2019
Title:
Methods To Mobilize Progenitor/Stem Cells
Applicant:
GENZYME CORPORATION
Oppositions:
98
Patent:
EP2397142
Grant Date:
Jul 27, 2022
Title:
Use Of Dpp Iv Inhibitors
Applicant:
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Oppositions:
90
Patent:
EP2350096
Grant Date:
Dec 11, 2019
Title:
Methods Of Treating Hepatic Encephalopathy
Applicant:
SALIX PHARMACEUTICALS, LTD.
Oppositions:
88
Patent:
EP2478907
Grant Date:
Apr 14, 2021
Title:
Methods And Compositions For Treating Cancer
Applicant:
COUGAR BIOTECHNOLOGY, INC.
Oppositions:
88
Patent:
EP3246021
Grant Date:
Nov 13, 2019
Title:
Apixaban Formulations
Applicant:
BRISTOL-MYERS SQUIBB HOLDINGS IRELAND
Oppositions:
72

Top companies filing oppositions in Organic Medicines industry

Company:
SANDOZ AG
Total oppositions filed:
180
Company:
STADA ARZNEIMITTEL AG
Total oppositions filed:
173
Company:
N.V. NUTRICIA
Total oppositions filed:
132
Company:
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Total oppositions filed:
130
Company:
GENERICS [UK] LIMITED
Total oppositions filed:
126
Company:
GENERICS (U.K.) LIMITED
Total oppositions filed:
125
Company:
SOCIETE DES PRODUITS NESTLE S.A.
Total oppositions filed:
123
Company:
TEVA PHARMACEUTICAL INDUSTRIES LTD
Total oppositions filed:
108
Company:
ALFRED E. TIEFENBACHER (GMBH & CO. KG)
Total oppositions filed:
103
Company:
HEXAL AG
Total oppositions filed:
92

Top companies facing oppositions in Organic Medicines industry

Company:
NOVARTIS AG
Total facing oppositions:
620
Company:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Total facing oppositions:
221
Company:
N.V. NUTRICIA
Total facing oppositions:
186
Company:
NOVARTIS PHARMA GMBH
Total facing oppositions:
126
Company:
SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Total facing oppositions:
124
Company:
NESTEC S.A.
Total facing oppositions:
121
Company:
PFIZER INC.
Total facing oppositions:
115
Company:
SALIX PHARMACEUTICALS, LTD.
Total facing oppositions:
97
Company:
AMGEN INC.
Total facing oppositions:
88
Company:
BRISTOL-MYERS SQUIBB HOLDINGS IRELAND
Total facing oppositions:
73

Need more information?

Feel free to send us a message here and we will get back to you